CIK 0001850119 · <br>Emerging growth company
Century Therapeutics, Inc.
Sign in to watch- Ticker
- IPSC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 842040295
- Phone
- 215-981-4000
- Business address
- 25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
- 4 Shares withheld for taxes SVP Finance & Operations gave up 16,611 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 20,763 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award SVP Finance & Operations acquired 120,846 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 151,058 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Scientific Officer acquired 7,452 shares (option exercise)
- 4 Open-market sale Chief Scientific Officer sold 144,911 shares at an average $3.73 ($539,879)
- 4 Derivatives Options or other derivatives
- 4 Grant or award VP Finance & Operations acquired 15,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Scientific Officer acquired 43,750 shares (grant or award)
Page 7 of 10 · 188 filings